DCF — MUSC HEALTH KERSHAW MEDICAL CENTER
Enterprise Value: $-244.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-244.7M
Enterprise Value
$-75.2M
PV of Cash Flows
$-169.5M
PV of Terminal Value
$-272.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $87.5M | $-16.4M | -19.0% | $-20.1M | $-18.3M |
| Year 2 | $90.1M | $-16.0M | -18.0% | $-19.9M | $-16.4M |
| Year 3 | $92.8M | $-15.6M | -17.0% | $-19.5M | $-14.7M |
| Year 4 | $95.6M | $-15.6M | -16.0% | $-19.6M | $-13.4M |
| Year 5 | $98.5M | $-15.8M | -16.0% | $-20.0M | $-12.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-244.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$85.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19294015510033996
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5